DE69001484T2 - Verwendung von menschlichen BCDF für die Herstellung einer Zusammensetzung für die Behandlung von Thrombocytopenia. - Google Patents

Verwendung von menschlichen BCDF für die Herstellung einer Zusammensetzung für die Behandlung von Thrombocytopenia.

Info

Publication number
DE69001484T2
DE69001484T2 DE90100371T DE69001484T DE69001484T2 DE 69001484 T2 DE69001484 T2 DE 69001484T2 DE 90100371 T DE90100371 T DE 90100371T DE 69001484 T DE69001484 T DE 69001484T DE 69001484 T2 DE69001484 T2 DE 69001484T2
Authority
DE
Germany
Prior art keywords
thrombocytopenia
manufacture
treatment
composition
human bcdf
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Revoked
Application number
DE90100371T
Other languages
English (en)
Other versions
DE69001484D1 (de
Inventor
Tadamitsu Kishimoto
Toshio Dr Hirano
Hideo Kimura
Toshiyuki Ishibashi
Yukio Akiyama
Akira Okano
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ajinomoto Co Inc
Original Assignee
Ajinomoto Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27277408&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69001484(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ajinomoto Co Inc filed Critical Ajinomoto Co Inc
Application granted granted Critical
Publication of DE69001484D1 publication Critical patent/DE69001484D1/de
Publication of DE69001484T2 publication Critical patent/DE69001484T2/de
Anticipated expiration legal-status Critical
Revoked legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/204—IL-6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
DE90100371T 1989-01-13 1990-01-09 Verwendung von menschlichen BCDF für die Herstellung einer Zusammensetzung für die Behandlung von Thrombocytopenia. Revoked DE69001484T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP695489 1989-01-13
JP16308789 1989-06-26
JP1282297A JP2805224B2 (ja) 1989-01-13 1989-10-30 血小板減少症治療剤

Publications (2)

Publication Number Publication Date
DE69001484D1 DE69001484D1 (de) 1993-06-09
DE69001484T2 true DE69001484T2 (de) 1994-01-05

Family

ID=27277408

Family Applications (1)

Application Number Title Priority Date Filing Date
DE90100371T Revoked DE69001484T2 (de) 1989-01-13 1990-01-09 Verwendung von menschlichen BCDF für die Herstellung einer Zusammensetzung für die Behandlung von Thrombocytopenia.

Country Status (5)

Country Link
US (2) US5126325A (de)
EP (1) EP0378171B1 (de)
JP (1) JP2805224B2 (de)
KR (1) KR960000395B1 (de)
DE (1) DE69001484T2 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6284237B1 (en) 1986-07-08 2001-09-04 Steven C. Clark Methods of treatment using IL-6
US6348191B1 (en) 1986-07-08 2002-02-19 Genetics Institute, Inc. Production and use of IL-6
EP0585957A1 (de) * 1986-08-06 1994-03-09 Ajinomoto Co., Inc. Rekombinanter B-Zell-Differenzierungsfaktor
JP2642103B2 (ja) * 1986-09-20 1997-08-20 佑 本庶 ヒトｂ組胞分化因子
US5202117A (en) * 1988-08-24 1993-04-13 Koichiro Tsuji Method of treating thrombi with g-csf
JPH0331215A (ja) * 1989-06-27 1991-02-12 Ajinomoto Co Inc 制癌療法支持剤
US5571508A (en) * 1989-12-18 1996-11-05 Amrad Corporation Limited Method for the treatment of thrombocytopenia and pharmaceutical compositions useful therefor
US5340719A (en) * 1990-11-23 1994-08-23 Corporation Coulter Method and apparatus for optically screening microscopic cells
EP0560998A4 (en) * 1991-10-09 1993-12-01 Toray Industries, Inc. Medicine for preventing and treating bleeding tendency
IL99803A (en) * 1991-10-20 1997-02-18 Yeda Res & Dev Pharmaceutical compositions comprising interleukin-6 for the treatment of chronic lymphocytic leukemia and B-cell lymphomas
IT1254359B (it) * 1992-05-11 1995-09-14 Serono Cesare Ist Ricerca Composizioni farmaceutiche contenenti il-6
MX9304075A (es) * 1992-07-08 1994-04-29 Applied Research Systems Composicion farmaceutica para el tratamiento o profilaxis de los desordenes trombohemorragicos consuntivos.
WO1994028919A1 (en) * 1993-06-08 1994-12-22 Ajinomoto Co., Inc. Hematopoietic cell proliferation accelerator
EP0734265A1 (de) * 1993-12-13 1996-10-02 Novartis AG IL - 6 Therapy
US5578301A (en) * 1993-12-14 1996-11-26 Sandoz Ltd. Method for using GM-CSF to reduce the acute phase response in a patient being administered IL-6 therapy
US5599536A (en) * 1993-12-13 1997-02-04 Sandoz Ltd. Method for suppressing the acute phase response in a patient receiving IL-6 therapy
US5547931A (en) * 1994-02-23 1996-08-20 Immtech International Inc. Methods of stimulatory thrombocytopoiesis using modified C-reactive protein
EP0721780A3 (de) * 1994-12-16 1997-12-17 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Mittel zur Förderung von Plättchen und/oder Leucozytenherstellung
JP2008024722A (ja) * 1996-02-01 2008-02-07 Chugai Pharmaceut Co Ltd 血小板減少症の予防剤および治療剤
US6509313B1 (en) * 1996-02-28 2003-01-21 Cornell Research Foundation, Inc. Stimulation of immune response with low doses of cytokines
ATE315390T1 (de) * 1998-11-17 2006-02-15 Smithkline Beecham Corp Zyklische polyamine zur behandlung der thrombozytopenie
KR100504219B1 (ko) * 2002-11-22 2005-07-27 주식회사 진영엘디엠 가구패널용 에지몰딩 스트립
CN112162098A (zh) * 2020-08-17 2021-01-01 中国人民解放军陆军军医大学第二附属医院 一组血清差异蛋白在制备用于检测人ⅱ型血小板减少症试剂中的应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE67035B1 (en) * 1986-07-08 1996-02-21 Genetics Inst Production and use of non-glycosylated IL-6
EP0585957A1 (de) * 1986-08-06 1994-03-09 Ajinomoto Co., Inc. Rekombinanter B-Zell-Differenzierungsfaktor

Also Published As

Publication number Publication date
JP2805224B2 (ja) 1998-09-30
US5310550A (en) 1994-05-10
KR900011474A (ko) 1990-08-01
JPH03101624A (ja) 1991-04-26
EP0378171A3 (en) 1990-09-19
DE69001484D1 (de) 1993-06-09
US5126325A (en) 1992-06-30
EP0378171A2 (de) 1990-07-18
KR960000395B1 (ko) 1996-01-06
EP0378171B1 (de) 1993-05-05

Similar Documents

Publication Publication Date Title
DE69001484T2 (de) Verwendung von menschlichen BCDF für die Herstellung einer Zusammensetzung für die Behandlung von Thrombocytopenia.
DE69104796D1 (de) Zusammensetzung für die Haarbehandlung.
DE59608738D1 (de) Verwendung von epinastin für die behandlung von schmerzen
ATE233236T1 (de) Zwischenprodukte für die herstellung von oximäthern
DE3779346D1 (de) Zusammensetzung zur behandlung der haut.
DE69109560T2 (de) Fungizide Zusammensetzung zur Behandlung von Saatgut.
DE3882775T2 (de) Zusammensetzung zur Behandlung von parodontaler Krankheit.
DE69103109T2 (de) Vorrichtungen zur Herstellung von Rädern mit Schrägverzahnung.
DE3789079T2 (de) Zusammensetzung für die Behandlung von Fasern.
ATE221763T1 (de) Die verwendung von glyceryltriacetat zur behandlung von onychomykosen
DE69207696T2 (de) Einschritt-Verfahren zur Herstellung von Dirithromycin
IT8320435A0 (it) Composizione per il trattamento dell'acne.
DE3785401T2 (de) Verwendung von Phenylethanolaminen zur Herstellung von Arzneimitteln, wirksam für gastrointestinale Beschwerden.
DE69007486D1 (de) Verwendung von calciumantagonisten für die behandlung von narben.
DE69408484D1 (de) 6,7-Dialkoxy-3,4-dihydroisochinolin-8-ol, Verfahren für seine Herstellung und die Verbindung verwendendes Verfahren für die Herstellung von 6,7-Dialkoxy-1,2,3,4-tetrahydroisochinolin-8-ol
DE69302799T2 (de) Zusammensetzung für die Behandlung von Kesselwasser
DE69101847D1 (de) Zubereitung für die Verhütung oder die Behandlung von Hypertriglyceridämie.
DE59204989D1 (de) Verwendung einer mischung für die herstellung von medizinischen implantaten
DE3582371D1 (de) Oxindolverbindungen, diese enthaltende zusammensetzungen sowie verfahren zur herstellung derselben.
DE69116216D1 (de) Verwendung von Squalene, Squalane oder deren Mischungen zur Herstellung einer abkühlenden Zusammensetzung zur örtlichen Behandlung von Verbrennungen
DE69013726T2 (de) Verbessertes Verfahren für die Herstellung von o-Carboxypyridyl- und o-Carboxychinolylimidazolinonen.
DE3784768T2 (de) Verwendung von zusammensetzungen auf basis von crotoxin, zur herstellung von medikamenten zur behandlung von carcinomen.
DE3483944D1 (de) Verwendung von selektiv peripheren dopamin-antagonisten zur herstellung eines arzneimittels zur topischen behandlung von okularer hypertension.
DE69014042T2 (de) Verfahren zur Herstellung von menschlichem Osteocalcin.
AT400095B (de) Zahnärztliches handstück für die behandlung von zähnen mit laserstrahlen

Legal Events

Date Code Title Description
8363 Opposition against the patent
8331 Complete revocation